Search

everythinglearnresearchcommunity

for

Search:↓

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

A man's health improved after treating his undiagnosed adrenal insufficiency, which caused fatigue and weight loss.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Women with PCOS have more emotional and body image issues than healthy women.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

People with early hair loss may have a higher chance of enlarged prostate and metabolic syndrome, so they should be checked for urinary and metabolic issues.

Robotic hair transplantation with AI offers more reliable, precise, and efficient hair restoration.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

There is no causal relationship between androgenetic alopecia and serum uric acid.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

NMN could potentially treat hair loss by reducing oxidative stress and improving cell health.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Early diagnosis and a combination of treatments, including minoxidil and finasteride, are recommended for managing hair loss in India.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.